It seems there's some misunderstanding here. The paper doesn't claim to have solved the issue but highlights areas requiring further research, particularly controlled clinical trials to confirm the effects. Intermittent fasting is indeed a complex and debated topic, as preclinical findings often don't translate directly into clinical practice.

I appreciate that you've spoken to oncologists and cancer nutritionists—real-world expertise is invaluable in discussions like this. Could you share any insights or perspectives they provided? It could help clarify and enrich the conversation for everyone.https://pakrozee.pk/

Thank you for the recommendation. Jake Seliger's insights on clinical trials have been incredibly helpful for many. His contributions will certainly continue to guide and inspire others. May he rest in peace. https://pakrozee.pk/

They're using weakened viruses. Virus use in cancer is nothing new, but an interesting field. I can see why pharma hesitates using it, viruses can mutate, too, similar to cancer. https://pakrozee.pk/